PBH NYSE
Prestige Consumer Healthcare Inc.
1W: -4.0%
1M: +1.0%
3M: -9.2%
YTD: -22.6%
1Y: -23.8%
3Y: -20.6%
5Y: -18.5%
$47.39
-0.76 (-1.58%)
Weekly Expected Move ±4.0%
$44
$46
$48
$50
$52
Credit Risk of going bust: higher than 51% of companies Debt: 47.9% of company value Bonds: $94.4M held by 117 funds, 137 bp over Treasuries → details ▾
Of US companies ranked in the middle of the pack, about 1 in 580 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $2.41 (down 95%), Prestige Consumer Healthcare Inc. would be worth roughly what it owes.
Total debt $2.06B against a stock market value of $2.25B.
Distance to default 5.06 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $1.01B (short-term plus half of long-term), stock volatility 33.1%; Altman Z'' 2.93. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.
If the stock fell to about $2.41 (down 95%), Prestige Consumer Healthcare Inc. would be worth roughly what it owes.
Total debt $2.06B against a stock market value of $2.25B.
Distance to default 5.06 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $1.01B (short-term plus half of long-term), stock volatility 33.1%; Altman Z'' 2.93. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
7 relationships7
As Filer
counterparties named
0
As Counterparty
mentioned by others
2
Rel. Types
2021-05-28
Earliest Filing
2025-08-07
Latest Filing
target: 4
acquirer: 3
Counterparties (Filed by PBH)
7 relationshipsCompanies named in PBH's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Medtech Pharma Holdings Limited | — | acquirer | Purchaser of Pillar5 Pharma Inc. shares | 2025-08-07 | View |
| Pillar5 Pharma Inc. | — | target | Target company being acquired by Medtech Pharma Holdings Limited | 2025-08-07 | View |
| ANJAC SAS | — | target | Seller of Pillar5 Pharma Inc. shares | 2025-08-07 | View |
| Medtech Products Inc. | — | acquirer | Wholly-owned subsidiary that acquired Akorn Consumer Health business assets | 2021-07-01 | View |
| Akorn Operating Company LLC | — | target | Seller of the Consumer Health business assets | 2021-07-01 | View |
| Medtech Products Inc. | — | acquirer | Wholly-owned subsidiary of Prestige Consumer Healthcare Inc. entering agreement to acquire assets from Akorn. | 2021-05-28 | View |
| Akorn Operating Company LLC | — | target | Delaware LLC selling a portfolio of over-the-counter consumer brands to Medtech Products Inc. | 2021-05-28 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-08-14 | Officer/Director Change | View | |
| 2026-08-06 | Earnings Release; Regulation FD; Exhibits | View | |
| 2026-07-15 | Material Agreement; Financial Obligation; Exhibits | Agreement | View |
| 2026-07-09 | Exhibits | View | |
| 2026-07-06 | Material Agreement; Financial Obligation; Regulation FD; Exhibits | Agreement | View |
| 2026-06-30 | Exhibits | View | |
| 2026-06-16 | Material Agreement; Acquisition/Disposition; Financial Obligation; Other Events; Exhibits | Agreement Acquisition | View |
| 2026-05-13 | Material Agreement; Earnings Release; Regulation FD; Exhibits | Agreement | View |
| 2026-03-20 | Material Agreement; Regulation FD; Other Events; Exhibits | Agreement | View |
| 2026-02-05 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View | |
| 2025-11-06 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View | |
| 2025-08-07 | Entry into Material Definitive Agreement; Results of Operations and Financial Condition; Regulation | Agreement | View |
| 2025-05-08 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View | |
| 2025-02-06 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View | |
| 2025-01-06 | Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits | View | |
| 2024-11-07 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View | |
| 2024-08-08 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View | |
| 2024-05-14 | Results of Operations and Financial Condition; Regulation FD Disclosure; Other Events; Financial Sta | View | |
| 2024-05-08 | Departure/Election of Directors; Appointment of Officers | View | |
| 2024-02-08 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR